Human insulin is being commercially produced from a transgenic species of
Rhizobium
Saccharomyces
Escherichia
Mycobacterium.
Which of the following is not an advantage of $GM$ crops?
The use of bioresources by multinational companies and other organisations without proper authorisation from the countries and people concerned without compensatory payment is called
Explants before organogenesis, is
Repeated transfusions of genetically modified cells are required in $SCID$ patients and in enzyme replacement therapy because
Find the incorrect statement